Movatterモバイル変換


[0]ホーム

URL:


ITMI20042189A1 - Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale - Google Patents

Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale

Info

Publication number
ITMI20042189A1
ITMI20042189A1IT002189AITMI20042189AITMI20042189A1IT MI20042189 A1ITMI20042189 A1IT MI20042189A1IT 002189 AIT002189 AIT 002189AIT MI20042189 AITMI20042189 AIT MI20042189AIT MI20042189 A1ITMI20042189 A1IT MI20042189A1
Authority
IT
Italy
Prior art keywords
probiotic bacteria
prevention
improvement
treatment
pathologies
Prior art date
Application number
IT002189A
Other languages
English (en)
Inventor
Giovanni Mogna
Gian Paolo Strozzi
Original Assignee
Anidral Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=35677517&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITMI20042189(A1)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Anidral SrlfiledCriticalAnidral Srl
Priority to IT002189ApriorityCriticalpatent/ITMI20042189A1/it
Publication of ITMI20042189A1publicationCriticalpatent/ITMI20042189A1/it
Priority to BRPI0517273Aprioritypatent/BRPI0517273B8/pt
Priority to DK05793656.9Tprioritypatent/DK1773361T4/da
Priority to JP2007542140Aprioritypatent/JP2008520640A/ja
Priority to PCT/IB2005/003214prioritypatent/WO2006054135A1/en
Priority to PL05793656Tprioritypatent/PL1773361T5/pl
Priority to PT05793656Tprioritypatent/PT1773361E/pt
Priority to HK08101361.1Aprioritypatent/HK1110510B/xx
Priority to RU2007106038/10Aprioritypatent/RU2418063C2/ru
Priority to ES05793656Tprioritypatent/ES2329390T5/es
Priority to EP05793656Aprioritypatent/EP1773361B2/en
Priority to DE602005015451Tprioritypatent/DE602005015451D1/de
Priority to KR1020077011176Aprioritypatent/KR101228608B1/ko
Priority to US11/719,027prioritypatent/US9233130B2/en
Priority to CN2005800327953Aprioritypatent/CN101031313B/zh

Links

Classifications

Landscapes

IT002189A2004-11-162004-11-16Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinaleITMI20042189A1 (it)

Priority Applications (15)

Application NumberPriority DateFiling DateTitle
IT002189AITMI20042189A1 (it)2004-11-162004-11-16Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
CN2005800327953ACN101031313B (zh)2004-11-162005-10-05基于益生菌的组合物及其在预防和/或治疗呼吸性病变和/或感染以及改善肠功能中的用途
US11/719,027US9233130B2 (en)2004-11-162005-10-05Probiotic bacteria based composition and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of the intestinal functionality
PL05793656TPL1773361T5 (pl)2004-11-162005-10-05Kompozycje oparte na bakteriach probiotycznych i ich zastosowanie w profilaktyce i/lub leczeniu patologii i/lub zakażeń układu oddechowego oraz poprawie funkcji jelit
RU2007106038/10ARU2418063C2 (ru)2004-11-162005-10-05Композиция на основе пробиотических бактерий и ее применение в профилактике и/или лечении респираторных патологий и/или инфекций и в улучшении функции кишечника
JP2007542140AJP2008520640A (ja)2004-11-162005-10-05プロバイオティクス細菌系組成物、ならびに、呼吸病態および/または呼吸器系感染の予防および/または治療、および腸機能改善へのその使用
PCT/IB2005/003214WO2006054135A1 (en)2004-11-162005-10-05Probiotic bacteria based composition and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of the intestinal functionality
BRPI0517273ABRPI0517273B8 (pt)2004-11-162005-10-05composição contendo uma mistura de três bactérias probióticas, uso desta para a prevenção e/ou tratamento de infecções do trato respiratório superior e na regularização da funcionalidade intestinal do organismo acometido por essas patologias e kit contendo uma mistura de três bactérias probióticas
PT05793656TPT1773361E (pt)2004-11-162005-10-05Composição baseada em bactérias probióticas e sua utilização na prevenção e/ou tratamento de patologias e/ou infecções respiratórias e na melhoria da funcionalidade intestinal
HK08101361.1AHK1110510B (en)2004-11-162005-10-05Probiotic bacteria based composition and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of the intestinal functionality
DK05793656.9TDK1773361T4 (da)2004-11-162005-10-05Sammensætning baseret på probiotiske bakterier og anvendelse deraf til forebyggelse og/eller behandling af respiratoriske sygdomme
ES05793656TES2329390T5 (es)2004-11-162005-10-05Composición a base de bacterias probióticas y uso de la misma en prevención y/o el tratamiento de infecciones y/o patologías respiratorias y en la mejora de la funcionalidad intestinal
EP05793656AEP1773361B2 (en)2004-11-162005-10-05Probiotic bacteria based composition and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of the intestinal functionality
DE602005015451TDE602005015451D1 (de)2004-11-162005-10-05Auf probiotischen bakterien basierende zusammensetzung und ihre verwendung zur vorbeugung und/oder behandlung von atemwegserkrankungen und/oder infektionen sowie zur verbesserung der darmtätigkeit
KR1020077011176AKR101228608B1 (ko)2004-11-162005-10-05프로바이오틱 박테리아 기초 조성물 및 호흡기 병리 및/또는 감염의 예방 및/또는 치료 및 장 기능성 개선에 있어서 그들의 용도

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
IT002189AITMI20042189A1 (it)2004-11-162004-11-16Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale

Publications (1)

Publication NumberPublication Date
ITMI20042189A1true ITMI20042189A1 (it)2005-02-16

Family

ID=35677517

Family Applications (1)

Application NumberTitlePriority DateFiling Date
IT002189AITMI20042189A1 (it)2004-11-162004-11-16Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale

Country Status (14)

CountryLink
US (1)US9233130B2 (it)
EP (1)EP1773361B2 (it)
JP (1)JP2008520640A (it)
KR (1)KR101228608B1 (it)
CN (1)CN101031313B (it)
BR (1)BRPI0517273B8 (it)
DE (1)DE602005015451D1 (it)
DK (1)DK1773361T4 (it)
ES (1)ES2329390T5 (it)
IT (1)ITMI20042189A1 (it)
PL (1)PL1773361T5 (it)
PT (1)PT1773361E (it)
RU (1)RU2418063C2 (it)
WO (1)WO2006054135A1 (it)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN115025132A (zh)*2022-06-092022-09-09康永波一种合生元组合物及其制备方法和应用

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
ITMI20042189A1 (it)2004-11-162005-02-16Anidral SrlComposizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
WO2007079147A2 (en)2005-12-282007-07-12Advanced Bionutrition CorporationA delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
EP2068899B1 (en)2006-10-022015-07-01DuPont Nutrition Biosciences ApSLactobacillus acidophilus for use in reducing the incidence and duration of respiratory infections
JP5689601B2 (ja)*2006-12-112015-03-25デュポン ニュートリション バイオサイエンシーズ エーピーエス組成物
CA2695366C (en)*2007-08-032016-10-04Shaklee CorporationNutritional supplement system
US9763989B2 (en)2007-08-032017-09-19Shaklee CorporationNutritional supplement system
WO2009021585A1 (en)*2007-08-132009-02-19Dsm Ip Assets B.V.Probiotic bacteria for rducing the occurence of symptoms of winter infections
WO2009048934A2 (en)*2007-10-112009-04-16Danisco A/SProbiotics for use in relieving symptoms associated with gastrointestinal disorders
ITMI20072260A1 (it)*2007-12-032009-06-04Anidral SrlUna composizione a base di batteri probiotici in associazione con un prebiotico e suo uso nella prevenzione e/o nel trattamento di patologie e/o infezioni respiratorie e nel miglioramento della funzionalita intestinale.
US20090280099A1 (en)*2008-05-072009-11-12Bachman Stephen ENasopharyngeal inoculate of probiotics and prebiotics for treatment of respiratory infections
RU2373275C1 (ru)*2008-07-152009-11-20Федеральное Государственное учреждение науки "Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н. Габричевского" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человекаШтамм bifidobacterium pseudocatenulatum ov-17, используемый для получения бактерийных препаратов, биологически активных добавок к пище, неферментированных пищевых продуктов, гигиенических и косметических средств
RU2373277C1 (ru)*2008-07-152009-11-20Федеральное Государственное учреждение науки "Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н. Габричевского" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человекаШтамм bifidobacterium angulatum ov-15, используемый для получения бактерийных препаратов, биологически активных добавок к пище, неферментированных пищевых продуктов, гигиенических и косметических средств
RU2373278C1 (ru)*2008-07-152009-11-20Федеральное Государственное учреждение науки "Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н. Габричевского" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человекаШтамм bifidobacterium pseudocatenulatum ov-2, используемый для получения бактерийных препаратов, биологически активных добавок к пище, неферментированных пищевых продуктов, гигиенических и косметических средств
JP5426850B2 (ja)*2008-08-192014-02-26株式会社日清製粉グループ本社インフルエンザワクチンのアジュバント
KR101001767B1 (ko)2008-11-042010-12-15주식회사한국야쿠르트항 인플루엔자 바이러스 효능을 갖는 락토바실러스 루테리 에이취와이7501 및 이를 유효성분으로 함유하는 제품
CN102215849A (zh)*2008-11-172011-10-12埃索姆股份公司含有链球菌菌株和乳杆菌菌株的组合的药物制剂
WO2010103132A1 (es)*2009-03-102010-09-16Hero España, S.A.Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
MY157343A (en)2009-05-262016-05-31Advanced Bionutrition CorpStable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
IT1397566B1 (it)*2009-05-272013-01-16Probiotical SpaLactobacillus pentosus produttore di batteriocine, composizioni alimentari e farmaceutiche contenenti lo stesso e relativo uso
WO2011044934A1 (en)*2009-10-142011-04-21Probiotical S.P.AProbiotic bacteria strains enabling of hydrolyzing prebiotic fibers and symbiotic compositions thereof
US20110123677A1 (en)*2009-11-252011-05-26Pepsico, Inc.High acid beverage products and methods to extend probiotic stability
FI20096400A0 (fi)*2009-12-282009-12-28Suomen Punainen Risti VeripalvVeriryhmästatuksen käyttö I
US9504750B2 (en)2010-01-282016-11-29Advanced Bionutrition CorporationStabilizing composition for biological materials
US8834951B2 (en)2010-01-282014-09-16Advanced Bionutrition CorporationDry glassy composition comprising a bioactive material
IT1398553B1 (it)*2010-03-082013-03-01Probiotical SpaComposizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
WO2011148219A1 (en)*2010-05-282011-12-01Compagnie Gervais DanoneProbiotic strains for use in improving the enteric nervous system
CL2010001124A1 (es)*2010-10-142011-01-21Univ De Concepcion 50% Ma Loreto Ormeno 50%Alimento funcional probiotico que comprende cepas viables de lactobacillus sp.; uso de dicho alimento funcional para contrarestar los efectos colaterales de la quimioterapia.
GB201110095D0 (en)*2011-06-152011-07-27DaniscoMethod of treatment
GB201112091D0 (en)2011-07-142011-08-31Gt Biolog LtdBacterial strains isolated from pigs
ITRM20110475A1 (it)*2011-09-092013-03-10Probiotical SpaCeppi di batteri lattici e/o bifido batteri, opzionalmente addizionati di n-acetilcisteina e/o lisozima microincapsulato gastroprotetto, aventi attivita' di inibizione/riduzione della crescita di differenti biotipi di e.coli, incluso e.coli o157:h7 e
ITRM20110477A1 (it)*2011-09-092013-03-10Giovanni MognaComposizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
GB201117313D0 (en)2011-10-072011-11-16Gt Biolog LtdBacterium for use in medicine
CN104080465A (zh)*2012-01-132014-10-01科.汉森有限公司用于预防或治疗上呼吸道感染的鼠李糖乳杆菌和动物双歧杆菌乳亚种
KR101381794B1 (ko)*2012-04-102014-04-07씨제이제일제당 (주)타가토스 및 프로바이오틱 유산균을 함유하는 신바이오틱 식품 조성물
KR101398977B1 (ko)*2012-11-142014-05-27대구가톨릭대학교산학협력단락토바실러스 카세이 유산균주 배양용 d-타가토오스 함유 배지 및 d-타가토오스첨가 요구르트의 제조방법
JP6349262B2 (ja)*2013-01-312018-06-27国立大学法人 香川大学血糖値の上昇抑制効果を有するこんにゃく加工飲食品
GB201306536D0 (en)2013-04-102013-05-22Gt Biolog LtdPolypeptide and immune modulation
CN104957260B (zh)*2014-03-072018-07-24内蒙古伊利实业集团股份有限公司具有缓解咽喉部炎症功效的益生菌食品组合物及食品
SMT201800291T1 (it)2014-12-232018-07-174D Pharma Res LimitedPolipeptide pirina e modulazione immunitaria
SG10201913609PA (en)2014-12-232020-03-304D Pharma Res LtdImmune modulation
SMT201900539T1 (it)2015-06-152019-11-134D Pharma Res LimitedComposizioni comprendenti ceppi batterici
MA41010B1 (fr)2015-06-152020-01-314D Pharma Res LtdCompositions comprenant des souches bactériennes
RS59446B1 (sr)2015-06-152019-11-294D Pharma Res LtdBlautia stercosis i wexlerae za upotrebu u lečenju inflamatornih i autoimunskih bolesti
EP3360559B1 (en)2015-06-152019-10-234D Pharma Research LimitedCompositions comprising bacterial strains
MA41060B1 (fr)2015-06-152019-11-294D Pharma Res LtdCompositions comprenant des souches bactériennes
CN105055438A (zh)*2015-07-212015-11-18珲春市神怡菌业生物科技开发有限公司一种具有改善胃肠道功能的香菇多糖益生元组合物
MY194231A (en)2015-07-292022-11-23Advanced Bionutrition CorpStable dry probiotic compositions for special dietary uses
ITUB20153106A1 (it)*2015-08-132017-02-13Probiotical SpaComposizione di batteri lattici per uso nel trattamento delle infezioni causate da Propionibacterium acnes e in particolare per l'acne
GB201520497D0 (en)2015-11-202016-01-064D Pharma Res LtdCompositions comprising bacterial strains
CA3005781C (en)2015-11-202019-01-224D Pharma Research LimitedCompositions comprising bacterial strains
GB201520638D0 (en)2015-11-232016-01-064D Pharma Res LtdCompositions comprising bacterial strains
GB201520631D0 (en)2015-11-232016-01-064D Pharma Res LtdCompositions comprising bacterial strains
ITUB20159330A1 (it)2015-12-222017-06-22Roelmi Hpc S R LComposizioni probiotiche e loro uso
KR101749222B1 (ko)*2016-01-042017-06-21주식회사 카브젖산균을 유효성분으로 포함하는 인플루엔자 바이러스 예방 및 치료용 조성물
CA3016179C (en)2016-03-042019-08-134D Pharma PlcCompositions comprising bacterial blautia strains for treating visceral hypersensitivity
GB201612191D0 (en)2016-07-132016-08-244D Pharma PlcCompositions comprising bacterial strains
TWI802545B (zh)2016-07-132023-05-21英商4D製藥有限公司包含細菌菌株之組合物
CN106177188A (zh)*2016-08-022016-12-07马南行一种用于女性抑菌平衡的益生菌组合物及其制备方法
GB201621123D0 (en)2016-12-122017-01-254D Pharma PlcCompositions comprising bacterial strains
WO2018125735A1 (en)*2016-12-292018-07-05Kibow Biotech, Inc.Composition and method for maintaining healthy kidney function
TW201907929A (zh)2017-05-222019-03-01英商4D製藥研究有限公司包含細菌品系之組成物
TW201907931A (zh)2017-05-242019-03-01英商4D製藥研究有限公司包含細菌菌株之組合物
PL3600363T3 (pl)2017-06-142021-06-144D Pharma Research LimitedKompozycje zawierające szczepy bakteryjne
WO2018229236A2 (en)2017-06-142018-12-204D Pharma Research LimitedCompositions comprising bacterial strains
LT3638271T (lt)2017-06-142021-01-114D Pharma Research LimitedKompozicijos, apimančios bakterines padermes
CN108295098A (zh)*2018-02-022018-07-20云南中京国建投资有限公司一种辅助降血糖的合生元组合物及其制剂与应用
CN112236154B (zh)*2018-05-312024-10-18深圳华大生命科学研究院一种组合物及其应用
KR101932955B1 (ko)2018-06-142018-12-27주식회사한국야쿠르트장내 균총 개선용 프로바이오틱스 조성물
TW202015712A (zh)*2018-07-032020-05-01學校法人北里研究所用以抑制流感之重症化的抗流感病毒劑
CN109432136A (zh)*2018-10-312019-03-08张志澎一种益生菌组合制剂及其制备方法和应用
CN110055185B (zh)*2018-12-252020-12-29江南大学一株具有抗流感能力的短双歧杆菌及其应用
CN109576185B (zh)*2018-12-262020-07-03江南大学一种具有抗流感能力的益生菌混合制剂及其应用
CN111544456A (zh)*2019-05-152020-08-18农绍汉一种益生菌配方及其应用
CN110051702A (zh)*2019-06-062019-07-26广东才俊创展商务服务有限公司一种防治手足口病、流感的益生菌配方
KR102328744B1 (ko)*2019-10-082021-11-22한국식품연구원락토바실러스 플란타럼 균주를 유효성분으로 포함하는 호흡기 질환 개선용 조성물
CN110946990B (zh)*2019-12-162023-05-23天津瑞普生物技术股份有限公司一种禽用呼吸道微生态喷雾制剂及其应用
CN111529703B (zh)*2020-06-172023-09-15湖南循天然营养有限公司一种组合物及其制备方法与在制备免疫佐剂中的应用
CN112056399A (zh)*2020-06-282020-12-11武汉康复得生物科技股份有限公司一种增强免疫力的益生菌组合物及其应用
KR20230098618A (ko)*2020-11-122023-07-04신바이오틱스 아베신바이오틱 조성물
TW202302128A (zh)*2021-03-262023-01-16香港中文大學微生物提高疫苗效力的用途
CN114657100B (zh)*2022-04-012023-07-25江南大学一株能够缓解流感病毒感染小鼠病理特征的戊糖乳杆菌及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US6241983B1 (en)1994-10-282001-06-05Metagenics, Inc.Bacteria-and fiber-containing composition for human gastrointestinal health
AUPN881396A0 (en)1996-03-201996-04-18Arnott's Biscuits LimitedEnhancement of microbial colonization of the gastrointestinal tract
JP4064481B2 (ja)*1996-10-112008-03-19ハウスウェルネスフーズ株式会社免疫賦活剤
EP2241616B1 (en)*1997-08-212012-11-28New Zealand Dairy BoardImmunity enhancing lactic acid bacteria
EP0904784A1 (en)1997-09-221999-03-31N.V. NutriciaProbiotic nutritional preparation
NL1010770C2 (nl)1998-12-092000-06-13Nutricia NvPreparaat dat oligosacchariden en probiotica bevat.
WO2001097821A1 (en)2000-06-192001-12-27Mucoprotec Pty LtdImmunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor.
FI110668B (fi)*2000-06-202003-03-14Aboatech Ab OyProbioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
GB2369777B (en)2000-10-052004-10-27St Ivel LtdFood products with antimicrobial lactic acid bacteria
FI109602B (fi)*2001-01-252002-09-13Valio OyProbioottiyhdistelmä
DE20202562U1 (de)2002-02-192002-05-23Orthomol pharmazeutische Vertriebs GmbH, 40764 LangenfeldMikronährstoffkombinationsprodukt mit Pro- und Prebiotika
ITMI20020399A1 (it)2002-02-282003-08-28Ct Sperimentale Del Latte S PComposizioni dietetiche e/o farmaceutiche per uso umano e/o animale abase di preparati microbici probiotici
US20050074442A1 (en)2002-03-132005-04-07Natarajan RanganathanCompositions and methods for augmenting kidney function
AU2003265296A1 (en)2002-07-222004-02-09Agtech Products, Inc.Lactobacillus strains and uses therefor
ES2290762T3 (es)2004-08-052008-02-16Anidral S.R.L.Cepas bacterianas de bifidobacterium que producen acido folico, sus formulaciones y utilizacion.
ITMI20042189A1 (it)2004-11-162005-02-16Anidral SrlComposizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
WO2007125558A1 (en)2006-05-032007-11-08Anidral S.R.L.Symbiotic composition comprising non-digestible polysaccharides and bifidobacteria which metabolize them and its uses
ITMI20072260A1 (it)2007-12-032009-06-04Anidral SrlUna composizione a base di batteri probiotici in associazione con un prebiotico e suo uso nella prevenzione e/o nel trattamento di patologie e/o infezioni respiratorie e nel miglioramento della funzionalita intestinale.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN115025132A (zh)*2022-06-092022-09-09康永波一种合生元组合物及其制备方法和应用
CN115025132B (zh)*2022-06-092024-01-30康永波一种合生元组合物及其制备方法和应用

Also Published As

Publication numberPublication date
ES2329390T3 (es)2009-11-25
RU2007106038A (ru)2008-10-27
EP1773361B1 (en)2009-07-15
EP1773361B2 (en)2012-09-26
CN101031313B (zh)2010-06-16
BRPI0517273B8 (pt)2021-05-25
WO2006054135A1 (en)2006-05-26
RU2418063C2 (ru)2011-05-10
CN101031313A (zh)2007-09-05
ES2329390T5 (es)2013-02-11
PL1773361T5 (pl)2012-12-31
PT1773361E (pt)2009-10-22
DK1773361T4 (da)2012-10-15
EP1773361A1 (en)2007-04-18
KR101228608B1 (ko)2013-02-01
DE602005015451D1 (de)2009-08-27
KR20070089130A (ko)2007-08-30
US9233130B2 (en)2016-01-12
HK1110510A1 (zh)2008-07-18
US20080107634A1 (en)2008-05-08
BRPI0517273B1 (pt)2020-11-03
DK1773361T3 (da)2009-11-16
PL1773361T3 (pl)2010-05-31
BRPI0517273A (pt)2008-10-07
JP2008520640A (ja)2008-06-19

Similar Documents

PublicationPublication DateTitle
ITMI20042189A1 (it)Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
PL1986669T3 (pl)Zastosowanie Bifidobacterium longum do zapobiegania i leczenia zapalenia
BRPI0616962B8 (pt)uso de lactobacillus para o tratamento de doenças autoimunes
EA200701820A1 (ru)Применение диосметиновых соединений при лечении и профилактике тромботических патологий
BR112015030389A2 (pt)uso de i) uma fonte de proteína, ii) um prebiótico e iii) um probiótico para a fabricação de uma composição nutricional para o tratamento ou a prevenção de infecção em um indivíduo alérgico
ECSP077238A (es)Composiciones para entrega de drogas altamente solubles en agua
NO20092639L (no)4-fenyl-6-(2,2,2-trifluor-1-fenyletoksy)pynmidinbaserte forbindelser og anvendelser derav
MX348797B (es)Microorganismos probioticos como agentes activos para mejorar el brillo de la tez de la piel.
EA200900613A1 (ru)Спирокетоновые ингибиторы ацетил-коа-карбоксилаз
NZ594814A (en)Peptide that is derived from a milk protein and has an antioxidative effect and also acts as a blood adiponectin level increase promotion and/or decrease inhibition agent
NZ617196A (en)Activin-actrii antagonists and uses for increasing red blood cell levels
MA33428B1 (fr)Agonistes du gpr119
EA201690265A3 (ru)Фармацевтические композиции, содержащие замещенные ациланилиды
EA200802166A1 (ru)Стабильная фармацевтическая композиция с защитным действием от раздражения (варианты), способ ее получения и способ лечения кальций-миметиком с ее помощью
BRPI0819323B8 (pt)composição à base de bactéria probiótica em associação com uma prebiótica e uso da mesma na prevenção e/ou tratamento de patologias respiratórias e/ou infecções e no aperfeiçoamento de funcionalidade intestinal
MX2010001449A (es)Bromhidrato de bupropion y aplicaciones terapeuticas.
TR200400363T4 (tr)Antibiyotikten / Antibiyotiklerden oluşan bir preparatın imalatı ve kullanımı
MY148276A (en)Long-term feed- elderly
BRPI0509053A (pt)composição farmacêutica anidra e uso de um agente siliconado e de uma composição
CL2008003602A1 (es)Compuestos derivados de triazolotriazinas y triazolopirazinas sustituidas; composicion farmaceutica; y su uso en el tratamiento y/o profilaxis de trastornos hematologicos.
ATE423114T1 (de)Aminocyclopropancarbonsäureamidderivate als bradykininantagonisten
EA200870584A1 (ru)Пролекарства пенема
FR2886851B1 (fr)Composition a base d'une avermectine et de metronidazole notamment pour le traitement de la rosacee
BRPI0519355A2 (pt)compostos para tratamento contra flaviviridae
GB0606015D0 (en)therapeutic agents

[8]ページ先頭

©2009-2025 Movatter.jp